Skip to main content
Bio Solution Co.,Ltd. logo

Bio Solution Co.,Ltd. — Investor Relations & Filings

Ticker · 086820 ISIN · KR7086820008 KO Manufacturing
Open in API
Filings indexed 214 across all filing types
Latest filing 2022-03-17 Major Shareholding Noti…
Country KR South Korea
Listing KO 086820

About Bio Solution Co.,Ltd.

https://bio-solution.co.kr/

Bio Solution Co., Ltd. is a biotechnology company focused on the development, manufacturing, and sale of cell therapy products. The company's core activities involve cell-based biotechnology, producing therapeutics such as autologous chondrocyte treatments for cartilage regeneration. In addition to its therapeutic offerings, Bio Solution develops human tissue models and provides alternative testing solutions. The company also manufactures and distributes a portfolio of bio-laboratory products, including ready-to-use kits, staining solutions, and various reagents for molecular biology research and development applications.

Recent filings

Filing Released Lang Actions
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 1% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership by major shareholders (specifically Jang Song-sun and related parties) due to the exercise of stock options. This type of filing is a mandatory disclosure for significant shareholding changes and does not fit into categories like Annual Reports, Earnings Releases, or Board Announcements. Therefore, it is classified as a Regulatory Filing (RNS).
2022-03-17 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 1% confidence The document is titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). This is a standard regulatory filing in South Korea (DART system) used by corporate insiders to disclose changes in their shareholdings, such as stock option exercises or trades. This corresponds to the 'Director's Dealing' category.
2022-03-17 Korean
주주총회소집공고
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a 'Notice of General Meeting of Shareholders' (주주총회소집공고) for Biosolution Co., Ltd. It contains the agenda for the 22nd Annual General Meeting, including items such as approval of financial statements, election of directors, and remuneration limits. This document is a formal proxy statement/notice sent to shareholders to inform them of the meeting and solicit their votes, which aligns with the definition of a Proxy Solicitation & Information Statement.
2022-03-14 Korean
주주총회집중일개최사유신고
AGM Information Classification · 1% confidence The document is a short regulatory filing (797 characters) submitted to the KRX (Korea Exchange) regarding the company's decision to hold its Annual General Meeting on a 'concentrated date' (a date when many companies hold their AGMs). It explains the internal reasons for this scheduling and references the official notice of the meeting. Since it is a regulatory disclosure regarding meeting logistics rather than the meeting materials themselves or the results, it falls under the general regulatory filing category.
2022-03-14 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 1% confidence The document is titled '의결권대리행사권유참고서류' (Reference Document for Solicitation of Proxy), which is a standard regulatory filing in South Korea for companies to solicit proxies from shareholders ahead of an Annual General Meeting (AGM). It contains details about the meeting, the agenda, and instructions for voting. While it includes some financial information, its primary purpose is proxy solicitation for the AGM, making it a Proxy Solicitation & Information Statement.
2022-03-14 Korean
주주총회소집결의
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집결의) for the company BioSolution. It details the date, location, agenda items (such as financial statement approval, director appointments, and business purpose changes), and provides specific biographical details for board nominees. This document is a standard proxy solicitation material sent to shareholders to inform them of the upcoming meeting and the items to be voted upon, which fits the definition of a Proxy Solicitation & Information Statement.
2022-03-10 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.